Impact of use of newer glucose lowering drugs on outcomes in patients with COVID-19

30/06/2020
21/03/2021
EU PAS number:
EUPAS36089
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Impact of use of newer glucose lowering drugs_v1.4_29.06.2020

English (374.66 KB - PDF) View document
Study results
Study results

Israelsen et al. 2021 DOM - Comparable COVID-19 outcomes with current use of GLP-1 RA, DPP-4i or SGLT2i among patients with diabetes who tested positive for SARS-CoV-2

English (399.47 KB - PDF) View document
Study report
Other information